Global-PPS HAI module

Diagnostics & Stewardship

Educational resources

The 2019 edition of World Antibiotic Awareness Week (WAAW), a World Health Organization (WHO) Global Health campaign, will take place from November 18th – 24th.

bioMérieux is an active advocate of the responsible use of antibiotics.

We are committed to raising awareness on the prudent use of antibiotics and the global healthcare threat of antibiotic resistance.

Together, let’s optimize antibiotic use

Global-PPS HAI module

One of the ways we raise antibiotic awareness is by supporting the development of surveillance tools, such as the Global Point Prevalence Survey (Global-PPS).

The Global-PPS is a worldwide surveillance initiative that measures antimicrobial resistance and healthcare-associated infection (HAI) rates, as well as antibiotic consumption.

Measuring HAI rates is a critical part of any hospital’s Antimicrobial Stewardship Program.

Today, the new Global-PPS HAI module - a free and user-friendly survey tool - is available to hospitals worldwide.

GET THE FREE HAI MODULE →

Surveillance of HAIs just got easier!

↑ Back to the top

What is the Global-PPS?

The Global-PPS is an annual survey coordinating surveillance of antimicrobial consumption, and HAI and resistance rates in hospitals worldwide.

In 2019, over 800 hospital networks in 50+ countries have taken part, gathering data on more than 250,000 patients.

The project is managed by the University of Antwerp (Belgium) and funded by bioMérieux.

Find out more on Global-PPS website

What benefits does the HAI module offer for my hospital?

Estimate the burden of HAI
Develop HAI surveillance
Maximize prevention of HAI and antimicrobial resistance
Raise awareness among healthcare workers

Want to know more about the HAI module? Watch the video below!

Diagnostics & Stewardship

In vitro diagnostic tests play an essential role in combatting the Antibiotic Resistance threat. Our extensive Antimicrobial Stewardship (AMS) diagnostics offer supports appropriate antibiotic use, helping to preserve their efficacy and curb antibiotic resistance.

It’s about having the right diagnostic tool to provide timely, relevant antimicrobial therapy information in every situation. See what just some of our AMS Diagnostic Solutions can do for you:

1. Deol P. et al. 2016; 26th ECCMID #EVO459

2. Lovern D., et al. Eur J Clin Microbiol Infect Dis., Dec 2016.

3. Rommler W., et al. Poster C-123, ASM Orlando, May 2006

4. Meisner M., et al. J Lab Med 1999;23:263-72

5. Schuetz P., et al. Crit care Med 2017 ; 45(5):781-789

6. Bouadma L., et al. Lancet 2010;375: DOI:10.1016/S0140-6736(09)61879-1

7. De Jong A., et al. The Lancet Infectious Diseases 2016 ; 16(7):819-827

8. Schuetz P., et al. Arch Intern Med 2011;171:1322-1331

BACT/ALERT® VIRTUO®, an automated instrument for faster blood culture

Fast & actionable results: Gain 4 hours on average
Avoid unnecessary patient treatment & supplementary testing: Improved sensitivity and specificity
Real-time notifications: Specific retrieval of positive bottles plus visual and audible alerts

VITEK® 2, an automated identification and antibiotic susceptibility testing analyzer

Same day results: in as little as 5 hours with customized reporting possible
Keep pace with pathogen evolution: regular updates of antibiotic breakpoints, and organism phenotypes

3

VIDAS® B.R.A.H.M.S PCT™, automated test to determine procalcitonin (PCT), a specific marker of severe bacterial infection and sepsis

Emergency situations: 20-minute results
Earlier antibiotic therapy: PCT levels detectable 3 – 6 hours after infectious challenge
Useful therapy information: antibiotic therapy monitoring - continue or stop antibiotics
Proven to be clinically useful for antibiotic stewardship: Sepsis and LRTI

4

8

VITEK® MS, Mass spectrometry microbial identification system

More specific treatment: Single choice identifications at the species, genus or group level
Rapid results: A few minutes is all it takes
Better discrimination between species: Report results based on a population-built database to cover most of your routine needs

BIOFIRE® FILMARRAY® PANELS, for syndromic testing with multiplex PCR system

Faster results: Approximately 1 hour for syndromic results of multitude of likely pathogens
Faster initiation of correct treatment: Increased capacity to detect co-infections
Less delay in processing samples: Easy to use by any technician at any time to increase emergency coverage to 24/7

↑ Back to the top

GET IN TOUCH NOW →

1

2

5

6,7

WE ARE FOR
ADVANCING ANTIMICROBIAL STEWARDSHIP

Educational Resources

FREE ACCREDITED WEBINAR!

“Value of Diagnostics in Antimicrobial Stewardship”
(An Asia-Pacific Outlook)

Dr Deborah Williamson is a Clinical Microbiologist and Deputy Director of the Microbiological Diagnostic Unit Public Health Laboratory (MDU PHL), Melbourne, Australia.

Dr David Lye is a Senior Consultant at the Institute of Infectious Diseases and Epidemiology (IIDE), Communicable Disease Centre, and Department of Infectious Diseases, Tan Tock Seng Hospital (TTSH), Singapore.

Tune in!

LEARN MORE ON AMR →